These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 15232416)

  • 21. Dermal absorption of benzene: implications for work practices and regulations.
    Kalnas J; Teitelbaum DT
    Int J Occup Environ Health; 2000; 6(2):114-21. PubMed ID: 10828140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzene and leukemia.
    Snyder R
    Crit Rev Toxicol; 2002 May; 32(3):155-210. PubMed ID: 12071572
    [No Abstract]   [Full Text] [Related]  

  • 23. Classification of risk occupation for benzene exposure by urine trans, trans-munconic acid level.
    Wiwanitkit V
    Asian Pac J Cancer Prev; 2006; 7(1):149-50. PubMed ID: 16629534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzene risk assessment: does new evidence on myelodysplastic syndrome justify a new approach?
    Li W; Schnatter AR
    Crit Rev Toxicol; 2018 Jul; 48(6):417-432. PubMed ID: 29745826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updating IARC's carcinogenicity assessment of benzene.
    Cogliano VJ; Baan R; Straif K;
    Am J Ind Med; 2011 Feb; 54(2):165-7. PubMed ID: 21259300
    [No Abstract]   [Full Text] [Related]  

  • 26. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industries. Part XXX: Causal relationship between chronic myelogenous leukemia and benzene-containing solvents.
    Mehlman MA
    Ann N Y Acad Sci; 2006 Sep; 1076():110-9. PubMed ID: 17119196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modes of action considerations in threshold expectations for health effects of benzene.
    North CM; Rooseboom M; Kocabas NA; Schnatter AR; Faulhammer F; Williams SD
    Toxicol Lett; 2020 Nov; 334():78-86. PubMed ID: 32941992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzene risk assessment: status of quantifying the leukemogenic risk associated with the low-dose inhalation of benzene.
    Voytek PE; Thorslund TW
    Risk Anal; 1991 Sep; 11(3):355-7. PubMed ID: 1947335
    [No Abstract]   [Full Text] [Related]  

  • 29. Shanghai Health Study (2001-2009): What was learned about benzene health effects?
    Gross SA; Paustenbach DJ
    Crit Rev Toxicol; 2018 Mar; 48(3):217-251. PubMed ID: 29243948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzene exposure and risk of non-Hodgkin lymphoma.
    Smith MT; Jones RM; Smith AH
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):385-91. PubMed ID: 17337645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China. Benzene Study Group.
    Linet MS; Yin SN; Travis LB; Li CY; Zhang ZN; Li DG; Rothman N; Li GL; Chow WH; Donaldson J; Dosemeci M; Wacholder S; Blot WJ; Hayes RB
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1353-64. PubMed ID: 9118920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicology and epidemiology of 1,3-butadiene.
    Himmelstein MW; Acquavella JF; Recio L; Medinsky MA; Bond JA
    Crit Rev Toxicol; 1997 Jan; 27(1):1-108. PubMed ID: 9115622
    [No Abstract]   [Full Text] [Related]  

  • 33. Hematological, myelotoxic, clastogenic, carcinogenic, and leukemogenic effects of benzene.
    van Raalte HG; Grasso P
    Regul Toxicol Pharmacol; 1982 Jun; 2(2):153-76. PubMed ID: 6764552
    [No Abstract]   [Full Text] [Related]  

  • 34. Projections of leukemia risk associated with occupational exposure to benzene.
    Infante PF; White MC
    Am J Ind Med; 1985; 7(5-6):403-13. PubMed ID: 3890530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of modeled benzene exposure and dose estimates published in the Chinese-National Cancer Institute collaborative epidemiology studies.
    Budinsky RA; DeMott RP; Wernke MJ; Schell JD
    Regul Toxicol Pharmacol; 1999 Dec; 30(3):244-58. PubMed ID: 10620474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk characterization and proposal of exposure thresholds to indoor chemical agents: the Index European project.
    Carrer P; Schlitt C; Koistinen K; Kephalopoulos S; Jantunen M; Kotzias D
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):368-70. PubMed ID: 18409729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in benzene risk assessment.
    Kacew S; Lemaire I
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):485-98. PubMed ID: 11086957
    [No Abstract]   [Full Text] [Related]  

  • 38. Current concepts of chronic benzene toxicity.
    Snyder R; Kocsis JJ
    CRC Crit Rev Toxicol; 1975 Jun; 3(3):265-88. PubMed ID: 1097190
    [No Abstract]   [Full Text] [Related]  

  • 39. Benzene exposure and leukemia.
    Goldstein B
    Epidemiology; 2004 Jul; 15(4):509-10. PubMed ID: 15232416
    [No Abstract]   [Full Text] [Related]  

  • 40. Occupational lymphohematopoietic cancer in Korea.
    Kim EA; Lee WJ; Son M; Kang SK
    J Korean Med Sci; 2010 Dec; 25(Suppl):S99-104. PubMed ID: 21258598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.